Sohini Das And Aneesh Phadnis

Stories by Sohini Das And Aneesh Phadnis

Lupin aims to enter Chinese market in the next one year

Lupin aims to enter Chinese market in the next one year

Rediff.com   8 Feb 2021

Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.

More Covid vaccine candidates get approval for clinical trials in India

More Covid vaccine candidates get approval for clinical trials in India

Rediff.com   6 Feb 2021

Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.

More Indians will take vaccine if politicians do: Survey

More Indians will take vaccine if politicians do: Survey

Rediff.com   5 Feb 2021

In India, Opposition parties along with healthcare professionals have urged the government, including Prime Minister Narendra Modi and top leaders, to take either of the Covishield or Covaxin doses, which could help in drastically reducing trust and fear issues amongst citizens., reports Sohini Das.

Ministry bats for coronavirus vaccines for aviation staff

Ministry bats for coronavirus vaccines for aviation staff

Rediff.com   25 Jan 2021

Railway employees including station masters, engine drivers, ticket checkers, etc too have been selected for vaccination and their list is being compiled for the exercise.

Why early applicant Pfizer's Covid vaccine is delayed

Why early applicant Pfizer's Covid vaccine is delayed

Rediff.com   19 Jan 2021

Pfizer sought to participate in the Subject Expert Committee consultations towards an emergency use authorisation for its Covid-19 vaccine. However, the company representatives have been unable to participate in the meetings because of extremely short notices of a few hours or less and time-zone limitations.

Serum Institute may supply 400 million doses to Gavi-Covax

Serum Institute may supply 400 million doses to Gavi-Covax

Rediff.com   19 Jan 2021

Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose.

V G Somani: The head of DCGI known as man of actions, not of words

V G Somani: The head of DCGI known as man of actions, not of words

Rediff.com   18 Jan 2021

'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'

Serum Institute began its journey in a small lab in stud farm

Serum Institute began its journey in a small lab in stud farm

Rediff.com   16 Jan 2021

The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the world, reports Sohini Das.

TCS' market capitalisation touches all-time high of Rs 12 trillion

TCS' market capitalisation touches all-time high of Rs 12 trillion

Rediff.com   15 Jan 2021

Currently, TCS is India's second most valuable firm after Reliance Industries, which has a market cap of nearly Rs 12.9 trillion.

As airlines spread wings, regional connectivity gets a boost

As airlines spread wings, regional connectivity gets a boost

Rediff.com   15 Jan 2021

While the number of operational airports in the country will rise to 131, other smaller towns too are seeing a surge in connectivity.

'It'll take 3-4 years to vaccinate 80% of population'

'It'll take 3-4 years to vaccinate 80% of population'

Rediff.com   11 Jan 2021

'We are hoping by March, the government allows us to export and give it to the private market.'

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Kids will have to wait for a COVID-19 vaccine

Kids will have to wait for a COVID-19 vaccine

Rediff.com   28 Dec 2020

The primary objective was to get the adult vaccine as children rarely have a severe form of the disease. Once schools reopen, the demand for vaccines for children under 12 may soar.

COVID vaccine: States to use bank guarantees

COVID vaccine: States to use bank guarantees

Rediff.com   26 Dec 2020

Each of the larger states may need less than Rs 10,000 crore each to finance the exercise.

In midst of holiday season, Dubai flights hit by seat allocation dispute

In midst of holiday season, Dubai flights hit by seat allocation dispute

Rediff.com   25 Dec 2020

Dispute arose as Indian carriers objected to Emirates flying passengers beyond Dubai, and Dubai authorities complained that Indian airlines have been flying more flights than allocated to its carriers.

Night curfew: New Year parties, travel plans fizzle out

Night curfew: New Year parties, travel plans fizzle out

Rediff.com   24 Dec 2020

Miffed hotels, restaurants stare at huge losses on account of advance planning for events that they now have to shelve.

Centre may not get costly Pfizer vaccine

Centre may not get costly Pfizer vaccine

Rediff.com   22 Dec 2020

At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.

Vaccine will be available to all

Vaccine will be available to all

Rediff.com   17 Dec 2020

The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.

 Covaxin shows robust response

Covaxin shows robust response

Rediff.com   17 Dec 2020

Bharat Biotech is in the middle of conducting a phase 3 trial with 22,000 subjects.